Literature DB >> 15291479

Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market.

Bengt-Göran Osterdahl1, Christer Jansson, Alexandre Paccou.   

Abstract

Moist snuff, or snus, on the Swedish market in 2001 and 2002 was analyzed for tobacco-specific N-nitrosamines (TSNAs) using a recently developed LC-MS/MS method. All samples of moist snuff analyzed were found to contain detectable levels of N'-nitrosonornicotine (NNN), N'-nitrosoanatabine (NAT), N'-nitrosoanabasine (NAB), and 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). In the survey in 2001, all samples except for one were produced by Swedish Match (n = 14), which is the dominating manufacturer on the Swedish snuff market. In the survey in 2002, samples from both Swedish Match (n = 7) and seven smaller manufacturers (n = 20) were analyzed. Total TSNA levels of between 0.15 and 3.0 microg/g wet weight were found. In the survey in 2001 and 2002, the mean level of the total TSNA content in moist snuff was 1.1 microg/g (n = 14) and 1.0 microg/g (n = 27), respectively. The result of the survey shows that the level of TSNAs in moist snuff on the Swedish market has been greatly reduced since the middle of the 1980s. Clearly, efforts have been made by the manufacturers to reduce the level of TSNAs in snuff.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291479     DOI: 10.1021/jf049931a

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  29 in total

1.  Role of snus in initiation and cessation of tobacco smoking in Sweden.

Authors:  L M Ramström; J Foulds
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

2.  Levels of toxins in oral tobacco products in the UK.

Authors:  A McNeill; R Bedi; S Islam; M N Alkhatib; R West
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

Review 3.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

4.  Analysis of Tobacco-Specific Nitrosamines in the Common Smokeless Tobacco Afzal in Oman.

Authors:  Nawal Al-Mukhaini; Taher Ba-Omar; Elsadig A Eltayeb; Aisha A Al-Shehi
Journal:  Sultan Qaboos Univ Med J       Date:  2016-02-02

5.  A Survey of N'-Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015.

Authors:  Jeffrey R Ammann; Katherine S Lovejoy; Matthew J Walters; Matthew R Holman
Journal:  J Agric Food Chem       Date:  2016-05-18       Impact factor: 5.279

6.  The STAGE cohort: a prospective study of tobacco use among Swedish twins.

Authors:  Helena Furberg; Paul Lichtenstein; Nancy L Pedersen; Laura Thornton; Cynthia M Bulik; Caryn Lerman; Patrick F Sullivan
Journal:  Nicotine Tob Res       Date:  2008-12       Impact factor: 4.244

7.  Alternative tobacco product use and smoking cessation: a national study.

Authors:  Lucy Popova; Pamela M Ling
Journal:  Am J Public Health       Date:  2013-03-14       Impact factor: 9.308

8.  Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry.

Authors:  Irina Stepanov; Peter W Villalta; Aleksandar Knezevich; Joni Jensen; Dorothy Hatsukami; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

9.  Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers.

Authors:  Alicia Allen; Rachel Isaksson Vogel; Ellen Meier; Amanda Anderson; Joni Jensen; Herbert H Severson; Dorothy Hatsukami
Journal:  Drug Alcohol Depend       Date:  2016-08-28       Impact factor: 4.492

10.  Snus use and other correlates of smoking cessation in the Swedish Twin Registry.

Authors:  H Furberg; P Lichtenstein; N L Pedersen; C M Bulik; C Lerman; P F Sullivan
Journal:  Psychol Med       Date:  2008-09       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.